Vitaprost forte, rectal 20 mg 10 pcs

Vitaprost® Forte has organotropic effect on the prostate.

It reduces the degree of edema and leucocytic infiltration of the prostate, normalizes the secretory function of epithelial cells, increases the number of lecithin granules in the atinus secretion, stimulates the muscle tone of the bladder.

It improves microcirculation in the prostate due to reduction of thrombogenesis, anti-aggregant activity, prevents development of venous thrombosis in the prostate.

Based on data of clinical trials it was proved that Vitaprost® Forte moderately decreases the prostate`s volume.

The drug reduces severity of obstructive and irritative symptoms of benign prostatic hyperplasia which is revealed through the increase of maximum and average volume rates of urine flow and reduction of residual urine volume.

Vitaprost® Forte improves blood microcirculation in the urinary bladder wall by dilating intact vessels (vasodilatation effect), thus restoring oxygen delivery to hypoxic tissues, which stimulates physiologic reparation.

It has anti-inflammatory effect by improving trophic processes in the bladder wall and stimulating regenerative processes.

Activation of the organ blood flow improves the adaptive and contractile activity of the detrusor and increases the bladder capacity.

The reduction of detrusor ischemia may explain the marked reduction of bladder hyperactivity, which continues after Vitaprost® Forte application.

Vitaprost® Forte helps to normalize the parameters of the prostate and ejaculate. It reduces pain and discomfort, eliminates dysuric phenomena, improves copulatory function.

Indications

Chronic prostatitis.
Benign prostatic hyperplasia.
Treatment of urgent (imperative) urinary incontinence, urgent (imperative) urge to urinate and frequent urination in uncomplicated forms of bladder overactivity in menopausal and postmenopausal women.
Conditions before and after surgical interventions on the prostate gland.

Pharmacological effect

Vitaprost® Forte has an organotropic effect on the prostate gland.

Reduces the degree of edema, leukocyte infiltration of the prostate gland, normalizes the secretory function of epithelial cells, increases the number of lecithin grains in the secretion of the acini, stimulates the muscle tone of the bladder.

Improves microcirculation in the prostate gland by reducing thrombus formation, antiplatelet activity, and prevents the development of venule thrombosis in the prostate gland.

Based on clinical research data, it has been proven that Vitaprost® Forte moderately reduces the volume of the prostate gland.

The drug reduces the severity of obstructive and irritative symptoms in benign prostatic hyperplasia, which is expressed in an increase in the maximum and average volumetric flow rates of urine and a decrease in the volume of residual urine.

Vitaprost® Forte improves blood microcirculation in the wall of the bladder due to the expansion of intact vessels (vasodilation effect), thereby helping to restore oxygen delivery to tissues experiencing hypoxia, which stimulates physiological repair.

It has an anti-inflammatory effect by improving trophic processes in the bladder wall and stimulating regenerative processes.

Activation of organ blood flow helps to improve the adaptive and contractile activity of the detrusor, increasing the capacity of the bladder.

A decrease in detrusor ischemia can explain the marked decrease in bladder hyperactivity, which continues after the end of Vitaprost® Forte use.

Vitaprost® Forte helps to normalize the parameters of the prostate gland and ejaculate. Reduces pain and discomfort, eliminates dysuric symptoms, improves copulative function.

Special instructions

Treatment of chronic prostatitis should be comprehensive, involving, along with the prescription of the drug Vitaprost® Forte, the use of other groups of drugs and non-drug treatment methods. Before starting treatment for chronic prostatitis and, if necessary, during treatment, it is recommended to analyze prostate secretions. During the period of use of the drug for the treatment of benign prostatic hyperplasia, you should regularly visit your doctor for standard monitoring of this disease. Before starting a course of treatment, you must make sure that the pathology is benign.

Active ingredient

Prostate extract

Active components

Prostate extract

Composition

1 rectal suppository contains:

Active ingredient:

Prostate extract (“Samprost” substance) 100 mg (in terms of water-soluble peptides – 20 mg),

Excipient:

Solid fat (vitepsol brand H15, W35; supposir brand NA15, NAS50) – sufficient amount to obtain a suppository weighing 1.25 g

Contraindications

Hypersensitivity to the components of the drug Vitaprost forte.

Side Effects

Often – 1-10%; sometimes – 0.1-1%; rarely – 0.01-0.1%; very rarely – less than 0.01%, including isolated cases. Very rarely – allergic reactions. If any of the above side effects get worse or you notice any other side effects not listed in the instructions, tell your doctor.

Interaction

Cases of interaction or incompatibility with other drugs have not been described.

Complete set of goods

Rectal suppositories 20 mg. 5 suppositories in a blister pack made of polyvinyl chloride film laminated with polyethylene. One or two blister packs along with instructions for medical use of the medicinal product in a cardboard pack.

Functional features

As a peptide drug, it is broken down by cellular proteases into amino acids. Has no cumulative effect.

Storage conditions

At a temperature not exceeding 25 °C. Keep out of the reach of children.

Shelf life

3 years. Do not use after the expiration date stated on the package.

Manufacturer

Nizhpharm JSC, Russia